These prompted us to study the involvement of ARL4C, as a KRAS downstream molecule, in aggressiveness of pancreatic cancer, and IQ-domain GTPase-activation protein 1 (IQGAP1) was identified as a binding protein of ARL4C. This evidence concerns the gene IQGAP1 and pancreatic neoplasm.